Literature DB >> 23100866

Glycoprotein components in the serum of patients with cancer breast.

M Varkey1, R S Devi, S B Rao.   

Abstract

The levels of total sialic acid, lipid bound sialic acid and fucose were estimated in the sera of patients with benign and malignant tumours of breast. An increase was noted in all the three parameters, with a more marked increase in malignancy, when compared with benign and controls. Consequent to surgery, there was an elevation in the serum levels of the above parameters than the values prior to surgery and a decline was noted two months after surgery although none of the values reached the normal range. These results suggest a close association of the glycoproteins with the tumour burden and further signify their role in early detection and staging of cancer breast.

Entities:  

Keywords:  Benign breast disease; Biomarkers; Cancer breast; Fucose; Lipid bound sialic acid; Total sialic acid

Year:  1997        PMID: 23100866      PMCID: PMC3454043          DOI: 10.1007/BF02867958

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  14 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Improved method to determine lipid bound sialic acid in plasma or serum.

Authors:  N Katopodis; C C Stock
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-10

3.  Glycolipids as indicators of tumorigenesis.

Authors:  D J Morré; T M Kloppel; W D Merritt; T W Keenan
Journal:  J Supramol Struct       Date:  1978

4.  Effects of dietary fat on age-dependent sensitivity to mammary carcinogenesis.

Authors:  P C Chan; T L Dao
Journal:  Cancer Lett       Date:  1983-04       Impact factor: 8.679

5.  Glycoproteins and human cancer. 1. Circulating levels in cancer serum.

Authors:  A Lipton; H A Harvey; S Delong; J Allegra; D White; M Allegra; E A Davidson
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

6.  Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.

Authors:  P S Patel; G N Raval; R R Rawal; G H Patel; D B Balar; P M Shah; D D Patel
Journal:  Cancer Lett       Date:  1994-07-29       Impact factor: 8.679

7.  Declining breast cancer mortality among young American women.

Authors:  W J Blot; S S Devesa; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

8.  Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.

Authors:  M C Plucinsky; W M Riley; J J Prorok; J A Alhadeff
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

Review 9.  The endocrinology of breast cancer.

Authors:  S G Korenman
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

10.  The effect of pre-morbid height and weight on the survival of breast cancer patients.

Authors:  S Tretli; T Haldorsen; L Ottestad
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

View more
  1 in total

1.  Assessment of serum L-fucose in brain tumor cases.

Authors:  S Manjula; Flama Monteiro; Annaya Rao Aroor; Suryanarayan Rao; Raja Annaswamy; Anjali Rao
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.